Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin vs dapagliflozin effect on glucagon response in metformin-treated type 2 diabetes
2015-001334-21Phase 4Completed
- Sponsor
- Lund University
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Vildagliptin add-on with Dapagliflozin add-on (2 arms). Primary endpoint: Glucagon AUC 0–180 min after mixed meal. Started Jun 2015; status: completed.
02
Drugs
vildagliptindapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-001334-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001334-21.